Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product, Surgery Type & End-User The global minimally invasive surgical instruments market will witness a robust CAGR of 7.21%, valued at $22.38 billion in 2021, expected to appreciate and reach $43.76 billion by 2030, confirms Strategic Market Research. Minimally Invasive Surgery (MIS) is a process that involves the conduction of surgical incisions for the reduction of trauma to the body. The surgery is performed by the usage of thin needles and an endoscope. MIS is widely used for cancer diagnostics, knee, and hip replacements, gallbladder problems, treatment of spinal disorders, heart and lung operations, etc. Cancer is one of the pivotal causes of death across the globe. According to GLOBOCAN 2020, the number of cancer cases rose to 19.3 Mn, and the total number of fatalities due to cancer reached a landmark of 10 Mn across the globe. According to THE CENTER (Orthopaedic and Neurosurgical Care and Research), almost 1 million knee and hip replacement surgeries are performed yearly in the United States. By 2030, the total number of knee replacement surgeries is estimated to grow by almost 67.3% (i.e., 3.5Mn procedures per year). In addition, approximately 60% of all knee implant surgeries are performed on women. Also, over 90 % of the people who had undergone knee replacement surgeries experienced a drastic reduction in knee pain. Also, the Minimally Invasive Glaucoma Surgery (Migs) devices help in reducing eye pressure along with the added benefits of a faster recovery time, which in turn is fuelling the overall market growth. All of the aforementioned statistics are highly expected to propel the overall market growth during the forecasted period of 2020-2030. Key Industry Drivers - Rising Prevalence of the Total Number of Surgeries Globally. The continuous increase in the number of MI surgeries worldwide such as(robotic surgery, Adrenalectomy, Brain surgery, Colectomy, Gallbladder surgery (cholecystectomy), Heart surgery, Kidney transplant, Nephrectomy (kidney removal), Spine surgery, Splenectomy, Cancer surgery, Colon and rectal surgery, Endovascular surgery, Gastroenterologic surgery, Neurosurgery, Orthopaedic surgery,Thoracic surgery, Otolaryngology, head and neck surgery, Urologic surgery, Robotic heart surgery, Minimally invasive heart surgery, Robotic hysterectomy, Robotic myomectomy, Robotic surgery, Non-robotic minimally invasive surgery (endoscopic surgery), weight loss surgery, Arthroscopic surgery, Natural orifice transluminal endoscopic surgery (NOTES), Parathyroidectomy, Video-assisted thoracoscopic surgery (VATS), repair of heart valves, supracervical hysterectomy, exploratory laparoscopy, percutaneous discectomy, minimally invasive cardiac surgery, minimally invasive knee replacement, robotic myomectomy, minimally invasive hip replacement, minimally invasive lumbar decompression, laparoscopic supracervical hysterectomy, minimally invasive mitral valve repair, minimally invasive aortic valve replacement, minimally invasive achilles bone spur surgery, minimally invasive back surgery) is one of the most major reasons that is driving the overall growth of the market. According to the National Library of Medicine, approximately 310 Mn surgeries are performed worldwide annually, nearly 40 to 50 Mn in the United States and 20Mn in Europe. Apart from the rise of surgical procedures, the increasing geriatric population worldwide is also greatly facilitating the minimally invasive surgical instruments market growth since geriatric people are more prone to chronic diseases like cardiovascular, orthopedic, and ophthalmic disorders. Besides the growth of the geriatric population, the rising prevalence of several diseases like Hiatal hernia, gastroesophageal reflux disease, Benign prostatic hyperplasia (BPH), median arcuate ligament syndrome (MALS), Rectal cancer, atrial fibrillation, mitral valve prolapses, bladder cancer, kidney cancer, etc. and some pivotal MIS tests like Bronchoscopy, Hysteroscopy, Sigmoidoscopy, and Vaginal access are driving the market growth extensively across the world. Restraints - Expensive MIS and Late FDA Approvals The higher cost of MIS is the major factor that is widely obstructing market growth worldwide. The total healthcare cost (direct and indirect) associated with MIS-TLIF amounts to USD 40000. Also, the huge delays in FDA approvals for launching the MIS instruments into the market are widely restraining the overall market growth. Opportunities - Rapid Technological Advancements and a Huge Demand for MIS Instruments in the Asia Pacific Region The rapid advancements in minimally invasive surgical technologies and a huge demand for the MIS instruments such as new surgical robots (Da Vinci Surgical Robot), and highly upgraded image guiding systems (ultrasound medical imaging, MRI, CT scan) are increasing continuously across the globe and are expected to grow exponentially in the future. According to Undark Magazine, in 2018, more than 1 million procedures were performed worldwide with the da Vinci Surgical Robot, and approximately 3 in 4 were performed in the United States. Moreover, according to JAMA (Journal of American Medical Association), the usage of robotic surgery for all general surgical procedures increased from 1.8% in 2012 to a staggering 15.1% in 2018. Also, the market for Minimally Invasive Surgical Instruments is growing rapidly in the Asia-Pacific region owing to its business-friendly environment and lenient regulatory policies, which in turn has drawn the market leaders to invest in MIS surgical instruments in this region in the future. Minimally Invasive Surgical Instruments Market Analysis Of Different Segments Covered in the Report Based on Product Handheld Instruments Cutting Instruments Inflation Devices Electrosurgical & Electrocautery Instruments Guiding Devices Others Based on Surgery Type Cardiothoracic Surgery Orthopedic Surgery Gastrointestinal Surgery Cosmetic Surgery Gynecological Surgery Urological Surgery Others Based on End-User Hospitals and Speciality Clinics Ambulatory Surgery Centers (ASCs) Others Regional Coverage Analysis North America US Mexico Canada Rest of North America Europe Switzerland Russia France Germany U.K Finland Turkey Netherlands Belgium Spain Italy Rest of Europe Asia Pacific China India Indonesia South Korea Thailand Japan Singapore Malaysia Philippines Australia Rest of Asia-Pacific LAMEA Brazil Saudi Arabia Uruguay Argentina Rest of LAMEA Minimally Invasive Surgical Instruments Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 22.38 Billion The revenue forecast in 2030 USD 43.76 Billion Growth rate CAGR of approximately 7.214% Base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Surgery Type, By End-users, By Region By Product Handheld Instruments, Cutting Instruments. Inflation Devices, Electrosurgical & Electrocautery Instruments, Guiding Devices, Others. By Surgery Type Cardiothoracic Surgery, Orthopaedic Surgery, Gastrointestinal Surgery, Cosmetic Surgery, Gynaecological Surgery, Urological Surgery, and Others. By End User Hospitals and Specialty Clinics, Ambulatory Surgery Centers (ASCs), Others. By Region North America, Europe, Asia Pacific, Rest of Asia-Pacific. Country Scope United States of America, United Kingdom, Italy, Germany, France, Spain, Canada, China, India, Japan, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, etc. Company Usability Profiles Medtronic plc, Johnson & Johnson, Smith & Nephew plc, Abbott Laboratories, Inc., B. Braun Melsungen AG, CONMED Corporation, Boston Scientific Corporation, Zimmer Biomet Holdings, Inc., Becton, Dickinson and Company, The Cooper Companies Inc., HOYA Corporation, Surgical Innovations Group plc, Koninklijke Philips N.V., FUJIFILM Holdings Corporation, KARL STORZ SE & Co. KG, Applied Medical Resources Corporation, STRAUSS SURGICAL, KLS Martin Group, Scanlan International, Inc., TROKAMED GmbH, Wexler Surgical, AMNOTEC International Medical GmbH, EndoMed Systems GmbH, Surgical Holdings. Segments Analysis & Insights Based on product, handheld instruments dominated the market in 2020 with a CAGR of 7.134 % and overall revenue of USD 4.683 billion. The increasing number of surgical procedures, lower cost of laparoscopic handheld surgical devices, and the rising technological innovations in handheld instruments are some of the pivotal factors that are fuelling the growth of this segment. Based on surgery type, cardiothoracic surgery dominated the market in 2020 with a steady CAGR. The factors such as an increase in the number of heart diseases, rising awareness of MIS instruments, and the increase in coronary and percutaneous cardio interventions are driving the overall growth of this segment. According to iData Research, the total number of cardiac surgeries yearly exceeds 9,00,000 in the United States. Based on end-users, the hospitals and specialty clinics segment significantly dominated the minimally invasive surgical instruments market in 2020. The continuous increase in the number of MI surgeries in hospitals due to the presence of high-skilled healthcare professionals is stimulating the growth of this segment. Based on Region, North America dominated the market in 2020, with a CAGR of 7.732% and overall revenue of 6.934 billion. A rise in the number of chronic diseases, highly developed healthcare infrastructure and systems, and a rise in expenditure in the healthcare sector by the government is accelerating the market growth in this region. Minimally Invasive Surgical Instruments Market Competitive Landscape Analysis The competitive landscape analysis provides adequate details about the pivotal competitors that exist in the market environment. The comparison is performed based on market initiatives, company overview, total revenue generation, market potential, investment in R&D, global presence, company financials, production capacity, company strengths and weaknesses, production sites and facilities, etc. The major players that are inculcated in the market report are: Medtronic plc Stryker Corporation Johnson & Johnson Smith & Nephew plc Abbott Laboratories, Inc. B. Braun Melsungen AG CONMED Corporation Boston Scientific Corporation Zimmer Biomet Holdings, Inc. Becton, Dickinson, and Company The Cooper Companies Inc. HOYA Corporation Surgical Innovations Group plc Koninklijke Philips N.V. FUJIFILM Holdings Corporation KARL STORZ SE & Co. KG Applied Medical Resources Corporation STRAUSS SURGICAL KLS Martin Group Scanlan International, Inc. TROKAMED GmbH Wexler Surgical AMNOTEC International Medical GmbH EndoMed Systems GmbH Surgical Holdings Recent Developments On August 2022, VISEON Inc. received the prestigious Quality Management certificate under the MDR or Medical Device Regulation of the European Union. The EU-MDR is regarded as the set of rules and regulations that effectively governs the global production & distribution of medical devices in the EU. Viseon, Inc. aims to advance the level of MI surgeries to such an extent that it will entirely change its market outlook in the future by improvising the surgical procedures, surgeon experiences, patient outcomes, etc. On Sep 2021, Medtronic expanded the MI Spine Surgery Ecosystem with the next generation of spinal technologies and became the only organization to provide combined data (i.e., the combination of biologics, spinal implants, robotics, navigation, and AI-powered data) to the surgeons worldwide. On Nov 2020, Johnson and Johnson unveiled its new Robot-Assisted Surgical System for providing more control and flexibility in the minimally invasive surgery processes. It contains a Zero-footprint design for enabling patient access and thus improving the overall workflow. On Oct 2020, Stryker Corporation proudly announced that it expanded its lateral spine portfolio by launching the Niagra Lateral Access System. The system plays a vital role in providing an integrated portfolio of MI lateral solutions to treat various kinds of spinal deformities among skeletally matured patients. The Instruments Developed by the Leading Manufacturers PRODUCT FUNCTION COMPANY ANTHEM Total Knee System It contains advanced tibial and femoral anatomic designs for facilitating the anatomic implant for all patients worldwide and also helps to improve the surgical method of knee prosthesis. Smith & Nephew Snowden-Pencer Ergonomic Laparoscopic Instruments It contains many jaw patterns and ergonomic handles to meet all the MIS needs with precision and comfort. Becton, Dickinson, and Company Anchor Tissue Retrieval System Provides comprehensive product offerings for safe and effective specimen retrieval according to the surgeon’s need. CONMED Corporation Clean Coat Laparoscopic Electrodes Helps in optimization of the overall performance in laparoscopic procedures. Medtronic Frequently Asked Question About This Report Which is the most dominant segment of the market based on the type of surgeries performed? Based on Surgery Type, the Cardiothoracic Surgery dominated the market in 2020 with a steady CAGR. Which is the leading End-user segment of the market? Based on End-User, the Hospitals and Speciality Clinics segment dominated the market significantly in 2020. What is the minimally invasive surgical instruments market growth? The global minimally invasive surgical instruments market is expected to grow at a compound annual growth rate (CAGR) of 7.214% from 2021 to 2030 to reach USD 43.76 Billion by 2030. How big is this minimally invasive surgical instruments Market size ? The global minimally invasive surgical instruments size was $22.38 Bn in 2021 and is predicted to reach $43.76 Bn by 2030, representing a CAGR of 7.214%. Which is the most dominant product segment of the market? Based on Product, Handheld Instruments dominated the market in 2020 with a CAGR of 7.134% and overall revenue of USD 4.683 billion. Who are the dominant players of the global market? The key players of the global market are Medtronic plc, Stryker Corporation, Johnson & Johnson, Smith & Nephew plc, Abbott Laboratories, Inc., B. Braun Melsungen AG, CONMED Corporation, Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Becton, Dickinson and Company, The Cooper Companies Inc, HOYA Corporation, Surgical Innovations Group plc, Koninklijke Philips N.V., Fujifilm Holdings Corporation, KARL STORZ SE & Co. KG, Applied Medical Resources Corporation, STRAUSS SURGICAL, KLS Martin Group, Scanlan International Inc, TROKAMED GmbH, Wexler Surgical, AMNOTEC International Medical GmbH, EndoMed Systems GmbH, and Surgical Holdings. Sources https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21660 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551172/ https://gro-md.com/blog/why-knee-replacements-are-more-common-in-women/ https://pubmed.ncbi.nlm.nih.gov/22120269/ https://pubmed.ncbi.nlm.nih.gov/31922557/ 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Minimally Invasive Surgical Instruments Market 4.2.1 Global Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global Market, by Region, 2021 - 2030 (USD Million) 4.4 Product Business Analysis 4.4.1 Global Market, By Product, 2021 - 2030 (USD Million) 4.5 End-User Business Analysis 4.5.1 Global Market, By End-User, 2021 - 2030 (USD Million) 4.5 Surgery Type Business Analysis 4.5.1 Global Market, By Surgery Type, 2021 - 2030 (USD Million) 4.6 Value Chain Analysis 4.7 Market Variable Analysis 4.7.1 Market Drivers Analysis 4.7.2 Market Restraints Analysis 4.8 Business Environment Analysis Tool 4.8.1 Market PEST analysis 4.8.2 Market Porter’s analysis 4.9 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2020) 5.11.2. Trends in Technology (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Minimally Invasive Surgical Instruments Manufacturing Sites, Area Served, Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Handheld Instruments 7.3.1. Handheld Instruments market, 2021 - 2030 (USD Million) 7.4. Cutting Instruments 7.4.1. Cutting Instruments market, 2021 - 2030 (USD Million) 7.4. Inflation Devices 7.4.1. Inflation Devices market, 2021 - 2030 (USD Million) 7.4. Electrosurgical & Electrocautery Instruments 7.4.1. Electrosurgical & Electrocautery Instruments market, 2021 - 2030 (USD Million) 7.4. Guiding Devices 7.4.1. Guiding Devices market, 2021 - 2030 (USD Million) 7.4. Others 7.4.1. Others market, 2021 - 2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals and Speciality Clinics 8.3.1. Hospitals and Speciality Clinics market, 2021 - 2030 (USD Million) 8.4. Ambulatory Surgery Centers (ASCs) 8.4.1. Ambulatory Surgery Centers (ASCs) market, 2021 - 2030 (USD Million) 8.5. Others 8.5.1. Others market, 2021 - 2030 (USD Million) 9. Global Surgery Type Market: By Surgery Type Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Cardiothoracic Surgery 9.3.1. Cardiothoracic Surgery market, 2021 - 2030 (USD Million) 9.4. Orthopaedic Surgery 9.4.1. Orthopaedic Surgery market, 2021 - 2030 (USD Million) 9.5. Gastrointestinal Surgery 9.5.1. Gastrointestinal Surgery market, 2021 - 2030 (USD Million) 9.6. Cosmetic Surgery 9.6.1. Cosmetic Surgery market, 2021 - 2030 (USD Million) 9.7. Gynaecological Surgery 9.7.1. Gynaecological Surgery market, 2021 - 2030 (USD Million) 9.8. Urological Surgery 9.8.1. Urological Surgery market, 2021 - 2030 (USD Million) 9.9. Others 9.9.1. Others market, 2021 - 2030 (USD Million) 9. Global Market: Regional Outlook 9.1 North America 9.1.1. North America Market, By Product, 2021 - 2030 (USD Million) 9.1.4. North America Market, By End-User, 2021 - 2030 (USD Million) 9.1.5. North America Market, by Country, 2021 - 2030 (USD Million) 9.1.4.1. U.S. 9.1.4.1.1. U.S. Market, By Product, 2021 - 2030 (USD Million) 9.1.4.2. Canada 9.1.4.2.1. Canada Market, By Product, 2021 - 2030 (USD Million) 9.1.4.2.2. Canada Market, By Region, 2021 - 2030 (USD Million) 9.1.4.2.3. Canada Market, by End-Users, 2021 - 2030 (USD Million) 9.2. Europe 9.2.1. Europe Market, By Product, 2021 - 2030 (USD Million) 9.2.2. Europe Market, by By End-User, 2021 - 2030 (USD Million) 9.2.5. Europe Market, by country, 2021 - 2030 (USD Million) 9.2.4.1 U.K. 9.2.4.1.1. U.K. Market, By Product, 2021 - 2030 (USD Million) 9.2.4.1.2. U.K. Market, By End-Users, 2021 - 2030 (USD Million) 9.2.4.1.3. U.K. Market, by Region, 2021 - 2030 (USD Million) 9.2.4.2. Germany 9.2.4.2.1. Germany Market, By Product, 2021 - 2030 (USD Million) 9.2.4.2.2. Germany Market, By End-User, 2021 - 2030 (USD Million) 9.2.4.2.3. Germany Market, by Region, 2021 - 2030 (USD Million) 9.2.4.3. France 9.2.4.3.1. France Market, By Product, 2021 - 2030 (USD Million) 9.2.4.3.2. France Market, By Region, 2021 - 2030 (USD Million) 9.2.4.3.3. France Market, by End-User, 2021 - 2030 (USD Million) 9.2.4.4. Rest of Europe 9.2.4.4.1. Rest of Europe Market, By Product, 2021 - 2030 (USD Million) 9.2.4.4.2. Rest of Europe Market, By Region, 2021 - 2030 (USD Million) 9.2.4.4.3. Rest of Europe Market, by End-User, 2021 - 2030 (USD Million) 9.3. Asia Pacific 9.3.1. Asia Pacific Market, By Product, 2021 - 2030 (USD Million) 9.3.2. Asia Pacific Market, By End-User, 2021 - 2030 (USD Million) 9.3.5. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 9.3.4.1. China 9.3.4.1.1. China Market, By Product, 2021 - 2030 (USD Million) 9.3.4.1.2. China Market, By Region, 2021 - 2030 (USD Million) 9.3.4.1.3. China Market, by End-User, 2021 - 2030 (USD Million) 9.3.4.2. India 9.3.4.2.1. India Market, By Product, 2021 - 2030 (USD Million) 9.3.4.2.2. India Market, By Region, 2021 - 2030 (USD Million) 9.3.4.2.3. India Market, by End-User, 2021 - 2030 (USD Million) 9.3.4.3. Japan 9.3.4.3.1. Japan Market, By Product, 2021 - 2030 (USD Million) 9.3.4.3.3. Japan Market, by End-User, 2021 - 2030 (USD Million) 9.3.4.4. South Korea 9.3.4.4.1. South Korea Market, By Product, 2021 - 2030 (USD Million) 9.3.4.4.3. South Korea Market, by End-User, 2021 - 2030 (USD Million) 9.3.4.5. Rest of ASIA PACIFIC 9.3.4.5.1. Rest of ASIA PACIFIC Market, By Product, 2021 - 2030 (USD Million) 9.3.4.5.3. Rest of ASIA PACIFIC Market, by End-User, 2021 - 2030 (USD Million) 9.4. Latin America 9.4.1. Latin America Market, By Product, 2021 - 2030 (USD Million) 9.4.3. Latin America Market, by End-User, 2021 - 2030 (USD Million) 9.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 9.4.4.1. Brazil 9.4.4.1.1. Brazil Market, By Product, 2021 - 2030 (USD Million) 9.4.4.1.3. Brazil Market, by End-User, 2021 - 2030 (USD Million) 9.4.4.2. Mexico 9.4.4.2.1. Mexico Market, By Product, 2021 - 2030 (USD Million) 9.4.4.2.3. Mexico Market, by End-User, 2021 - 2030 (USD Million) 9.4.4.3. Rest of the Latin America 9.4.4.3.1. Rest of the Latin America Market, By Product, 2021 - 2030 (USD Million) 9.4.4.3.3. Rest of the Latin America Market, by End-User, 2021 - 2030 (USD Million) 9.5. MEA 9.5.1. MEA Market, By Product, 2021 - 2030 (USD Million) 9.5.3. MEA Market, by End-User, 2021 - 2030 (USD Million) 10. Competitive Landscape 10.1 Medtronic plc. 10.1.1. Company overview 10.1.2. Financial performance 10.1.3. Product Portfolio Analysis 10.1.4. Business Strategy & Recent Development 10.2. Stryker Corporation. 10.2.1. Company overview 10.2.2. Financial performance 10.2.3. Product Portfolio Analysis 10.2.4. Business Strategy & Recent Development 10.3. Johnson & Johnson. 10.3.1. Company overview 10.3.2. Financial performance 10.3.3. Product Portfolio Analysis 10.3.4. Business Strategy & Recent Development 10.4. Smith & Nephew plc. 10.4.1. Company overview 10.4.2. Financial performance 10.4.3. Product Portfolio Analysis 10.4.4. Business Strategy & Recent Development 10.5. Abbott Laboratories, Inc 10.5.1. Company overview 10.5.2. Financial performance 10.5.3. Product Portfolio Analysis 10.5.4. Business Strategy & Recent Development 10.6. B. Braun Melsungen AG. 10.6.1. Company overview 10.6.2. Financial performance 10.6.3. Product Portfolio Analysis 10.6.4. Business Strategy & Recent Development 10.7. CONMED Corporation. 10.7.1. Company overview 10.7.2. Financial performance 10.7.3. Product Portfolio Analysis 10.7.4. Business Strategy & Recent Development 10.8. Boston Scientific Corporation 10.8.1. Company overview 10.8.2. Financial performance 10.8.3. Product Portfolio Analysis 10.8.4. Business Strategy & Recent Development 10.9. Zimmer Biomet Holdings, Inc. 10.9.1. Company overview 10.9.2. Financial performance 10.9.3. Product Portfolio Analysis 10.9.4. Business Strategy & Recent Development 10.10. Becton, Dickinson and Company. 10.10.1. Company overview 10.10.2. Financial performance 10.10.3. Product Portfolio Analysis 10.10.4. Business Strategy & Recent Development 10.11. The Cooper Companies Inc. 10.11.1. Company overview 10.11.2. Financial performance 10.11.3. Product Portfolio Analysis 10.11.4. Business Strategy & Recent Development 10.12. HOYA Corporation. 10.12.1. Company overview 10.12.2. Financial performance 10.12.3. Product Portfolio Analysis 10.12.4. Business Strategy & Recent Development 10.13. Surgical Innovations Group plc. 10.13.1. Company overview 10.13.2. Financial performance 10.13.3. Product Portfolio Analysis 10.13.4. Business Strategy & Recent Development 10.14. Koninklijke Philips N.V.. 10.14.1. Company overview 10.14.2. Financial performance 10.14.3. Product Portfolio Analysis 10.14.4. Business Strategy & Recent Development 10.15. FUJIFILM Holdings Corporation. 10.15.1. Company overview 10.15.2. Financial performance 10.15.3. Product Portfolio Analysis 10.15.4. Business Strategy & Recent Development 10.16. KARL STORZ SE & Co. KG. 10.16.1. Company overview 10.16.2. Financial performance 10.16.3. Product Portfolio Analysis 10.16.4. Business Strategy & Recent Development 10.17. Applied Medical Resources Corporation. 10.17.1. Company overview 10.17.2. Financial performance 10.17.3. Product Portfolio Analysis 10.17.4. Business Strategy & Recent Development 10.18. STRAUSS SURGICAL. 10.18.1. Company overview 10.18.2. Financial performance 10.18.3. Product Portfolio Analysis 10.18.4. Business Strategy & Recent Development 10.19. KLS Martin Group. 10.19.1. Company overview 10.19.2. Financial performance 10.19.3. Product Portfolio Analysis 10.19.4. Business Strategy & Recent Development 10.20. Scanlan International, Inc. 10.20.1. Company overview 10.20.2. Financial performance 10.20.3. Product Portfolio Analysis 10.20.4. Business Strategy & Recent Development 10.21. TROKAMED GmbH . 10.21.1. Company overview 10.21.2. Financial performance 10.21.3. Product Portfolio Analysis 10.21.4. Business Strategy & Recent Development 10.22. Wexler Surgical. 10.22.1. Company overview 10.22.2. Financial performance 10.22.3. Product Portfolio Analysis 10.22.4. Business Strategy & Recent Development 10.23. AMNOTEC International Medical GmbH. 10.23.1. Company overview 10.23.2. Financial performance 10.23.3. Product Portfolio Analysis 10.23.4. Business Strategy & Recent Development 10.24. EndoMed Systems GmbH. 10.24.1. Company overview 10.24.2. Financial performance 10.24.3. Product Portfolio Analysis 10.24.4. Business Strategy & Recent Development 10.25. Surgical Holdings. 10.25.1. Company overview 10.25.2. Financial performance 10.25.3. Product Portfolio Analysis 10.25.4. Business Strategy & Recent Development List of Tables (83 Tables) TABLE 1. Market, By Product, 2021-2030 (USD Million) TABLE 2. Market FOR Handheld Instruments, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Cutting Instruments, BY REGION, 2021-2030 (USD Million) TABLE 4. Market FOR Inflation Devices, BY REGION, 2021-2030 (USD Million) TABLE 5. Market FOR Electrosurgical & Electrocautery Instruments, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Guiding Devices, BY REGION, 2021-2030 (USD Million) TABLE 7. Market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 8. Market, By Surgery Type, 2021-2030 (USD Million) TABLE 9. Market FOR Cardiothoracic Surgery, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Orthopaedic Surgery, BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR Gastrointestinal Surgery, BY REGION, 2021-2030 (USD Million) TABLE 12. Market FOR Cosmetic Surgery, BY REGION, 2021-2030 (USD Million) TABLE 13. Market FOR Gynaecological Surgery, BY REGION, 2021-2030 (USD Million) TABLE 14. Market FOR Urological Surgery, BY REGION, 2021-2030 (USD Million) TABLE 15. Market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 16. Market, BY END-USER, 2021-2030 (USD Million) TABLE 17. Market FOR Hospitals and Speciality Clinics, BY REGION, 2021-2030 (USD Million) TABLE 18. Market FOR Ambulatory Surgery Centers (ASCs), BY REGION, 2021-2030 (USD Million) TABLE 19. Market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 20. Market, BY REGION, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA Market, BY End-Users, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA Market, By Product, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA Market, BY END-USER, 2021-2030 (USD Million) TABLE 25. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 26. EUROPE Market, By Product, 2021-2030 (USD Million) TABLE 27. EUROPE Market, BY END-USER, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC Market, By Product, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC Market, BY END-USER, 2021-2030 (USD Million) TABLE 31. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 32. LAMEA Market, By Product, 2021-2030 (USD Million) TABLE 33. LAMEA Market, BY END-USER, 2021-2030 (USD Million) TABLE 34. Medtronic plc: COMPANY SNAPSHOT TABLE 35. Medtronic plc: OPERATING SEGMENTS TABLE 36. Stryker Corporation.: COMPANY SNAPSHOT TABLE 37. Stryker Corporation: OPERATING SEGMENTS TABLE 38. Johnson & Johnson : COMPANY SNAPSHOT TABLE 39. Johnson & Johnson : OPERATING SEGMENTS TABLE 40. Smith & Nephew plc: COMPANY SNAPSHOT TABLE 41. Smith & Nephew plc: OPERATING SEGMENTS TABLE 42. Abbott Laboratories, Inc: COMPANY SNAPSHOT TABLE 43. Abbott Laboratories, Inc: OPERATING SEGMENTS TABLE 44. B. Braun Melsungen AG: COMPANY SNAPSHOT TABLE 45. B. Braun Melsungen AG: OPERATING SEGMENTS TABLE 46. CONMED Corporation: COMPANY SNAPSHOT TABLE 47. CONMED Corporation: OPERATING SEGMENTS TABLE 48. Boston Scientific Corporation: COMPANY SNAPSHOT TABLE 49. Boston Scientific Corporation: OPERATING SEGMENTS TABLE 50. Zimmer Biomet Holdings, Inc: COMPANY SNAPSHOT TABLE 51. Zimmer Biomet Holdings, Inc: OPERATING SEGMENTS TABLE 52. Becton, Dickinson and Company: COMPANY SNAPSHOT TABLE 53. Becton, Dickinson and Company: OPERATING SEGMENTS TABLE 54. The Cooper Companies Inc: COMPANY SNAPSHOT TABLE 55. The Cooper Companies Inc: OPERATING SEGMENTS TABLE 56. HOYA Corporation: COMPANY SNAPSHOT TABLE 57. HOYA Corporation: OPERATING SEGMENTS TABLE 58. Surgical Innovations Group plc: COMPANY SNAPSHOT TABLE 59. Surgical Innovations Group plc: OPERATING SEGMENTS TABLE 60. Koninklijke Philips N.V.: COMPANY SNAPSHOT TABLE 61. Koninklijke Philips N.V.: OPERATING SEGMENTS TABLE 62. FUJIFILM Holdings Corporation: COMPANY SNAPSHOT TABLE 63. FUJIFILM Holdings Corporation: OPERATING SEGMENTS TABLE 64. KARL STORZ SE & Co. KG: COMPANY SNAPSHOT TABLE 65. KARL STORZ SE & Co. KG: OPERATING SEGMENTS TABLE 66. Applied Medical Resources Corporation: COMPANY SNAPSHOT TABLE 67. Applied Medical Resources Corporation: OPERATING SEGMENTS TABLE 68. STRAUSS SURGICAL: COMPANY SNAPSHOT TABLE 69. STRAUSS SURGICAL: OPERATING SEGMENTS TABLE 70. KLS Martin Group: COMPANY SNAPSHOT TABLE 71. KLS Martin Group: OPERATING SEGMENTS TABLE 72. Scanlan International, Inc: COMPANY SNAPSHOT TABLE 73. Scanlan International, Inc: OPERATING SEGMENTS TABLE 74. TROKAMED GmbH: COMPANY SNAPSHOT TABLE 75. TROKAMED GmbH: OPERATING SEGMENTS TABLE 76. Wexler Surgical: COMPANY SNAPSHOT TABLE 77. Wexler Surgical: OPERATING SEGMENTS TABLE 78. AMNOTEC International Medical GmbH: COMPANY SNAPSHOT TABLE 79. AMNOTEC International Medical GmbH: OPERATING SEGMENTS TABLE 80. EndoMed Systems GmbH: COMPANY SNAPSHOT TABLE 81. EndoMed Systems GmbH: OPERATING SEGMENTS TABLE 82. Surgical Holdings: COMPANY SNAPSHOT TABLE 83. Surgical Holdings: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 25 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Minimally Invasive Surgical Instruments, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Minimally Invasive Surgical Instruments, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-Users, 2019 vs. 2025 (USD Million) Figure 12 Market, By Surgery Type, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 Figure 14 Geographical Snapshot of the Market Figure 15 Handheld Instruments to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 16 Hospitals and Speciality Clinics to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 17 Cardiothoracic Surgery to Witness Higher CAGR in Market for Surgery Type Segment during Forecast Period. Figure 18 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 Europe: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview